PerSimiO Ltd. is an Israeli startup company whose mission is to commercialize fifteen years of academic research and development on bone biomechanical simulation. PerSimiO offers a superior prediction technology, based on proprietary simulation of the response of human bones to load. The founders have validated the technology by ex-vivo experiments on a large cohort of human bones, using routine CT scans.
PerSimiO has obtained a provisional patent and plans to file for a patent in the USA and Europe in 2016. Although our team has applied the technology primarily to femur-related conditions, we plan to expand the list of Simfini applications to address fractures of the humerus and other long bones.